Cargando…

The silent epidemic of substandard and falsified medicines in low- and middle-income countries: heed lessons from the tragic deaths of children in Indonesia

Detalles Bibliográficos
Autores principales:	MohanaSundaram, ArunSundar, Padhi, Bijaya K., Mohanty, Aroop, Shrestha, Sunil, Sah, Ranjit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389216/ https://www.ncbi.nlm.nih.gov/pubmed/36906790 http://dx.doi.org/10.1097/JS9.0000000000000059

Ejemplares similares

Substandard and Falsified Medicines in Myanmar
por: Sakuda, Mirai, et al.
Publicado: (2020)

Taking cognizance of the risks associated with COVID-19, vaccine, and treatment in liver transplant recipients – A commentary on “The urgency of the Covid-19 vaccine in liver transplantation patients: What, how, and when?” [Int. J. Surg. 100 (Suppl) (2022) 106492)]
por: MohanaSundaram, ArunSundar, et al.
Publicado: (2022)

Strides toward a better understanding of the “Current efforts and challenges facing responses to Monkeypox in United Kingdom”
por: MohanaSundaram, ArunSundar, et al.
Publicado: (2023)

Long COVID-19 and used cooking oil consumption in India: The potential for concurrent and cascading scourges – Correspondence
por: MohanaSundaram, ArunSundar, et al.
Publicado: (2022)

The economic impact of substandard and falsified antimalarial medications in Nigeria
por: Beargie, Sarah M., et al.
Publicado: (2019)

Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance?
por: Zabala, Guillermo A, et al.
Publicado: (2022)

Monkeypox (Mpox) vaccines and their side effects: the other side of the coin
por: Sah, Ranjit, et al.
Publicado: (2023)

Combatting Substandard and Falsified Medicines: A View from Rwanda
por: Binagwaho, Agnes, et al.
Publicado: (2013)

The need for comprehensive and multidisciplinary training in substandard and falsified medicines for pharmacists
por: Ferrario, Alessandra, et al.
Publicado: (2019)

Substandard, falsified and unregistered medicines in Latin America, 2017-2018
por: Rojas-Cortés, Robin
Publicado: (2020)

Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
por: Jackson, Kathryn D., et al.
Publicado: (2020)

End of the COVID-19 pandemic: Is it a reality?
por: Rohilla, Ranjana, et al.
Publicado: (2023)

A resurgence of Sleeping sickness amidst the COVID-19 pandemic: Correspondence
por: Sah, Ranjit, et al.
Publicado: (2023)

Technologies for Detecting Falsified and Substandard Drugs in Low and Middle-Income Countries
por: Kovacs, Stephanie, et al.
Publicado: (2014)

A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
por: Tabernero, Patricia, et al.
Publicado: (2022)

Substandard and falsified medical products: bibliometric analysis and mapping of scientific research
por: Sweileh, Waleed M.
Publicado: (2021)

Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications
por: El-Dahiyat, Faris, et al.
Publicado: (2021)

Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
por: Pisani, Elizabeth, et al.
Publicado: (2021)

Mobile apps for detecting falsified and substandard drugs: A systematic review
por: Ciapponi, Agustín, et al.
Publicado: (2021)

Falsified and substandard medicines trafficking: A wakeup call for the African continent
por: Wada, Yusuf Hassan, et al.
Publicado: (2022)

The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
por: Cavany, Sean, et al.
Publicado: (2023)

Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania
por: Pisani, Elizabeth, et al.
Publicado: (2019)

Fostering a deeper understanding of COVID-19-associated mucormycosis – A commentary on “The mucormycosis coinfection in the context of global COVID-19 outbreak: A fatal addition to the pandemic spectrum” (Int. J. Surg. 2021:106031)
por: MohanaSundaram, ArunSundar, et al.
Publicado: (2021)

Evaluating Low-Cost Optical Spectrometers for the Detection of Simulated Substandard and Falsified Medicines
por: Wang, Wenbo, et al.
Publicado: (2019)

Falsified and substandard cardiovascular drugs in Africa: a need for continued monitoring strategies
por: Antignac, Marie, et al.
Publicado: (2019)

The scourge of substandard and falsified medical products gets worse with COVID-19 pandemic
por: Shiferie, Fisseha, et al.
Publicado: (2020)

Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines
por: Akpobolokemi, Tamara, et al.
Publicado: (2022)

Substandard and Falsified Medications: A Barrier to Global Health Equity Exemplified in Ecuador
por: Yakhkind, Aleksandra, et al.
Publicado: (2022)

Monkeypox and occupational exposure: Potential risk toward healthcare workers and recommended actions
por: Sah, Ranjit, et al.
Publicado: (2022)

XBB.1.5 an emerging threat: correspondence
por: Mohanty, Aroop, et al.
Publicado: (2023)

Outbreak of an emerging zoonotic Nipah virus: An emerging concern
por: Paul, Diptanu, et al.
Publicado: (2023)

Detection of SARS-CoV-2 infections in passengers arriving from China and their implications on air travel and public health in Italy
por: Sah, Ranjit, et al.
Publicado: (2023)

Can a Smartphone Application Help Address Barriers to Reporting Substandard/Falsified Medical Products? A Pilot Study in Tanzania and Indonesia
por: Wagnild, Janelle M., et al.
Publicado: (2023)

Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
por: Almuzaini, Tariq, et al.
Publicado: (2013)

Blockchain Technology for Detecting Falsified and Substandard Drugs in Distribution: Pharmaceutical Supply Chain Intervention
por: Sylim, Patrick, et al.
Publicado: (2018)

Retracted and Republished: A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR
por: Tabernero, Patricia, et al.
Publicado: (2019)

Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries
por: Hauk, Cathrin, et al.
Publicado: (2021)

A critical review on the availability of substandard and falsified medicines online: Incidence, challenges and perspectives
por: Ahmed, Jamee, et al.
Publicado: (2022)

Measles outbreak in American Samoa: Alarm to strengthen vaccination post COVID-19 pandemic
por: Zaman, Kamran, et al.
Publicado: (2023)

Stigma during monkeypox outbreak
por: Sah, Ranjit, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t8k321oj6g7hu5ecv8uut6fece